Related Experiment Video
Updated: Oct 26, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pseudomonas aeruginosa necrotizing bronchopneumonia
1University of Arizona, College of Medicine, Department of Pediatrics, Tucson, Arizona, USA.
Insights
Extremely low birth weight infants face high infection risks. A case study highlights Pseudomonas aeruginosa
Area of Science:
- Neonatalogy
- Infectious Diseases
- Microbiology
Background:
- Extremely low birth weight (ELBW) infants possess immature immune systems, increasing susceptibility to infections.
- Neonatal infections in ELBW infants correlate with elevated mortality, impaired growth, and adverse neurodevelopmental outcomes.
- Pseudomonas aeruginosa (P. aeruginosa) is an uncommon but severe pathogen causing pneumonia and sepsis in ELBW neonates, often as a healthcare-associated infection (HAI).
Purpose of the Study:
- To describe a case of P. aeruginosa infection in an ELBW infant.
- To discuss factors contributing to the pathogenesis and multidrug resistance of P. aeruginosa in this vulnerable population.
Main Methods:
- Case report of an extremely low birth weight infant.
- Review of factors related to P. aeruginosa pathogenesis and antibiotic resistance.
Main Results:
- An ELBW infant born at 26 weeks' gestation died at 13 days of life due to P. aeruginosa infection.
- The study discusses P. aeruginosa's ability to adapt and develop antibiotic resistance.
Conclusions:
- P. aeruginosa poses a significant threat to extremely low birth weight infants.
- Understanding P. aeruginosa pathogenesis and resistance mechanisms is crucial for managing infections in neonatal intensive care units.
Abstract:
Extremely low birth weight (ELBW) infants are at particularly high risk for infection due to an immature immune system, invasive procedures such as endotracheal intubation, intravascular catheterization, and other factors. Neonatal infections in this population are associated with a high mortality, poor growth, and neurodevelopmental outcomes. Pseudomonas aeruginosa (P. aeruginosa) infection is an uncommon but potentially devastating cause of pneumonia and sepsis in the ELBW population. P. aeruginosa is an important cause of healthcare-associated infections (HAI) or nosocomial infections. P. aeruginosa can perceive unfavorable environmental changes and orchestrate adaptations by developing plasmid-mediated and adaptive resistance to antibiotics. We describe an ELBW infant born at 26 weeks' gestation who succumbed at 13 days of life to P. aeruginosa infection. Some of the factors related to the pathogenesis and multidrug resistance are described.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

